Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › WV › RANSON › JEFFERSON MEMORIAL HOSPITAL

JEFFERSON MEMORIAL HOSPITAL

NPI: 1891722377 · RANSON, WV 25438 · Critical Access Hospital · NPI assigned 06/28/2006

$21.65M
Total Medicaid Paid
345,550
Total Claims
283,086
Beneficiaries
202
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialQUINONES, KATHLEEN (INTERIM VP FINANCE)
Parent OrganizationWEST VIRGINIA UNIVERSITY HOSPITALS EAST INC
NPI Enumeration Date06/28/2006

Related Entities

Other providers sharing the same authorized official: QUINONES, KATHLEEN

ProviderCityStateTotal Paid
BILLINGS CLINIC BILLINGS MT $53.85M
CITY HOSPITAL, INC MARTINSBURG WV $41.06M
BILLINGS CLINIC BILLINGS MT $15.71M
BILLINGS CLINIC BILLINGS MT $3.32M
BILLINGS CLINIC BILLINGS MT $2.99M
BILLINGS CLINIC BILLINGS MT $2.40M
BILLINGS CLINIC CODY WY $110K
BILLINGS CLINIC BILLINGS MT $97K
BILLINGS CLINIC BILLINGS MT $20K
BILLINGS CLINIC LIVINGSTON MT $2K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 56,927 $3.93M
2019 39,697 $2.32M
2020 72,411 $5.68M
2021 70,486 $4.66M
2022 34,552 $1.79M
2023 40,413 $1.82M
2024 31,064 $1.45M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 14,875 12,432 $1.85M
74177 Computed tomography, abdomen and pelvis; with contrast material 2,420 2,136 $1.68M
99283 Emergency department visit for the evaluation and management, moderate severity 15,853 13,704 $1.43M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 7,728 6,119 $1.15M
80053 Comprehensive metabolic panel 28,373 22,858 $978K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 29,697 23,406 $862K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 7,902 5,813 $810K
74176 Computed tomography, abdomen and pelvis; without contrast material 1,440 1,285 $807K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 7,886 6,438 $642K
96361 Intravenous infusion, hydration; each additional hour 4,966 3,733 $568K
70450 Computed tomography, head or brain; without contrast material 2,360 2,113 $534K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 10,013 8,099 $532K
71045 Radiologic examination, chest; single view 6,081 5,003 $410K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3,355 2,547 $396K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 3,364 3,077 $356K
96375 Therapeutic injection; each additional sequential IV push 6,254 4,787 $332K
87086 Culture, bacterial; quantitative colony count, urine 9,491 8,116 $313K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 2,027 1,833 $258K
71275 Computed tomographic angiography, chest, with contrast material 468 400 $258K
36415 Collection of venous blood by venipuncture 17,898 14,339 $252K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 3,663 2,421 $246K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 4,097 3,702 $239K
81001 9,840 8,305 $238K
84484 6,500 4,972 $235K
84443 Thyroid stimulating hormone (TSH) 5,654 5,218 $198K
71046 Radiologic examination, chest; 2 views 2,240 2,004 $187K
83690 5,130 4,298 $159K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,510 1,348 $157K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2,407 2,212 $157K
80061 Lipid panel 3,800 3,574 $152K
J2405 Injection, ondansetron hydrochloride, per 1 mg 5,243 4,110 $137K
85610 5,635 4,624 $135K
85730 4,823 4,018 $131K
88305 Level IV - Surgical pathology, gross and microscopic examination 673 560 $130K
72125 Computed tomography, cervical spine; without contrast material 404 361 $113K
83036 Hemoglobin; glycosylated (A1C) 3,715 3,443 $111K
77067 Screening mammography, bilateral, including computer-aided detection 540 490 $109K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,204 1,021 $105K
83605 3,002 2,367 $105K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 380 336 $104K
84702 2,872 2,411 $102K
76830 Ultrasound, transvaginal 445 403 $101K
96376 1,662 1,074 $101K
G0378 Hospital observation service, per hour 670 272 $100K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,255 1,145 $95K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 3,303 2,376 $95K
J1885 Injection, ketorolac tromethamine, per 15 mg 4,503 3,760 $91K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 803 717 $91K
76705 Ultrasound, abdominal, real time with image documentation; limited 399 359 $90K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,515 1,035 $89K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 2,584 2,349 $84K
0202U Oncology (prostate), multianalyte, gene expression profiling 359 292 $82K
87186 2,525 2,255 $81K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 4,109 3,518 $80K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2,475 2,008 $79K
93971 249 227 $78K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2,483 2,013 $78K
J2250 Injection, midazolam hydrochloride, per 1 mg 1,017 803 $78K
83880 2,462 1,964 $77K
81025 1,616 1,407 $75K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 754 602 $70K
80048 Basic metabolic panel (calcium, ionized) 2,196 1,808 $68K
86803 1,219 1,044 $63K
82607 1,121 1,028 $63K
J0690 Injection, cefazolin sodium, 500 mg 538 363 $61K
87040 1,455 1,075 $60K
84439 870 803 $59K
76801 201 173 $55K
71250 173 157 $54K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 482 309 $51K
87077 1,489 1,317 $50K
86850 1,271 1,068 $49K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 73 71 $48K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1,330 1,147 $47K
J2270 Injection, morphine sulfate, up to 10 mg 1,577 1,141 $47K
82728 688 634 $47K
83735 2,031 1,612 $43K
85379 812 704 $42K
86901 1,432 1,184 $41K
94760 1,162 709 $39K
87070 988 833 $39K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 1,056 716 $39K
88142 1,545 1,181 $38K
87340 942 786 $37K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 139 121 $34K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1,270 1,131 $33K
86140 1,407 1,226 $32K
81003 1,508 1,322 $31K
J2550 Injection, promethazine hcl, up to 50 mg 270 218 $31K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 647 573 $31K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 43 39 $31K
84703 427 389 $30K
72110 184 173 $29K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 659 570 $28K
71260 Computed tomography, thorax, diagnostic; with contrast material 57 51 $28K
86900 1,432 1,184 $27K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 718 558 $27K
73562 285 248 $27K
84145 616 532 $25K
82570 730 679 $25K
85027 488 411 $25K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 101 98 $24K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 162 138 $23K
73630 224 206 $22K
87088 571 499 $21K
73610 214 207 $20K
74018 185 171 $20K
84466 334 312 $19K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 899 741 $19K
80179 224 198 $18K
86780 802 649 $18K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 856 734 $17K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 244 224 $16K
77063 Screening digital breast tomosynthesis, bilateral 297 271 $15K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 12 12 $15K
J1650 Injection, enoxaparin sodium, 10 mg 458 237 $15K
73030 149 134 $15K
85007 324 259 $14K
83540 373 347 $14K
J2765 Injection, metoclopramide hcl, up to 10 mg 174 150 $14K
82803 254 200 $12K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 812 641 $11K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 68 64 $11K
72131 26 24 $11K
94644 150 126 $11K
86762 289 221 $10K
94664 214 167 $9K
73130 101 94 $9K
82043 285 273 $9K
87205 378 325 $8K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 13 12 $8K
85652 474 428 $8K
J0696 Injection, ceftriaxone sodium, per 250 mg 842 595 $8K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 26 26 $8K
90472 Immunization administration, each additional vaccine (list separately) 325 231 $7K
87147 296 257 $7K
80050 General health panel 82 78 $7K
J1200 Injection, diphenhydramine hcl, up to 50 mg 471 331 $7K
99281 Emergency department visit for the evaluation and management, self-limited or minor 142 136 $7K
82746 126 115 $7K
86618 194 99 $6K
87653 153 144 $6K
83615 222 180 $5K
G0475 Hiv antigen/antibody, combination assay, screening 120 101 $5K
96367 140 113 $5K
36600 197 131 $4K
45380 Colonoscopy, flexible; with biopsy, single or multiple 16 16 $4K
87210 132 108 $4K
85651 156 143 $4K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 15 15 $4K
87522 Neg quan hep c or qual rna 30 24 $4K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 383 314 $4K
Q3014 Telehealth originating site facility fee 110 103 $3K
82550 89 67 $3K
74019 42 37 $3K
84550 90 73 $2K
87081 85 82 $2K
J2704 Injection, propofol, 10 mg 432 305 $2K
96127 85 45 $2K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 89 62 $2K
82274 77 76 $2K
84156 49 39 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 41 28 $2K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 78 58 $2K
82950 69 68 $2K
86706 46 43 $2K
73110 16 14 $2K
59025 Fetal non-stress test 18 12 $2K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 69 58 $2K
92551 101 80 $1K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 38 28 $1K
99173 86 70 $1K
J7060 5% dextrose/water (500 ml = 1 unit) 140 81 $1K
86038 43 38 $1K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 256 198 $1K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 33 29 $1K
73502 18 18 $1K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 165 146 $1K
82248 31 28 $1K
80143 130 118 $1K
J3490 Unclassified drugs 1,763 1,053 $988.40
J2060 Injection, lorazepam, 2 mg 223 159 $932.91
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 123 113 $887.99
84100 37 28 $728.10
80076 17 17 $591.65
90710 19 13 $488.11
90715 12 12 $478.36
82565 13 13 $469.85
84520 13 13 $446.64
J7510 Prednisolone oral, per 5 mg 12 12 $391.06
90686 79 60 $377.77
90671 63 43 $298.04
86431 14 12 $246.51
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 13 13 $202.61
86617 14 14 $151.54
J3010 Injection, fentanyl citrate, 0.1 mg 214 167 $147.33
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg 15 13 $43.42
90648 50 40 $21.38
J3370 Injection, vancomycin hcl, 500 mg 18 12 $19.17
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program 13 12 $0.02
90723 46 31 $0.00
90680 16 13 $0.00